Weight-loss drug cuts heart attack risk regardless of kilograms shed, study finds

<p>Semaglutide study suggests such drugs could have wider benefits, though researchers find shrinking waistlines linked to better heart outcomes</p><p>The weight-loss drug semaglutide cuts the risk of heart attack or stroke regardless of how many kilograms people lose, the largest study of its kind has found.</p><p>However, shrinking waist size – a sign of less belly fat – was linked to better heart outcomes, according to the research.</p> <a href="https://www.theguardian.com/science/2025/oct/22/weight-loss-drug-cuts-heart-attack-risk-no-matter-how-many-kgs-are-shed-study-finds">Continue reading...</a>